Answers are grounded in this paper and cite their sources.
There is a necessity to better characterize uveal melanoma (UM) tumors according to their metastasis potential at an early stage. In this study we report the identification of potential biomarkers by a combination of proteomics-related approaches: the characterization of UM cell secretomes, the analysis of UM autoantibodies, and the differential depleted serum proteome analysis. We describe a possible role of cathepsin D, syntenin, and gp100 in UM as potential biomarkers.
No takes yet. Share an insight, caveat, or question.
Pardo et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: